• Home
  • Background
    Human papillomavirus and cervical cancer Vaccination Screening
  • About RISCC
    Research topics Partners Associated organisations
  • News
  • Publications
  • For Partners
  • Contact
  • Newsletter
About RISCC
  • Research topics
  • Partners
  • Associated organisations
EmbleemEU.png
  1. RISCC
  2. About RISCC
  3. Partners

Partners

The RISCC consortium is a collaboration between 11 European institutions. For more information on the expertise of each of the partners and the involved researchers, click on the name of one of the institutions below.

  • Amsterdam University Medical Center, location VUmc
  • Karolinska Institutet
  • International Agency for Research on Cancer
  • Pirkanmaa Hospital District
  • Catalan Institute of Oncology
  • Sciensano
  • University of Ljubljana
  • Self-screen B.V.
  • European Society of Gynaecological Oncology
  • Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino
  • Stockholms Lans Landsting

RISCC logo
NEWS
Risk of CIN 3+ in HPV+ Women with Normal Cytology and 5 year Type Concordance (Publication)
28 January 2021
Consortium meeting (December 9th)
15 December 2020
Interview Prof. Berkhof
25 October 2020
Direct effect of HPV vaccination on lifetime risk of precancer (Publication)
30 July 2020
Follow @RISCC_H2020

RISCC - Copyright 2021.
×